Belzutifan for treating tumours associated with von Hippel-Lindau disease [ID3932]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Belzutifan for previously treated advanced renal cell carcinoma [ID6154]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Renal cell carcinoma Pathways Pilot [ID6186]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Nivolumab for adjuvant treatment of localised renal cell carcinoma [ID6362]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC